Preproenkephalin knockout mice show no depression-related phenotype

Area of Science:

• Neuroscience
• Pharmacology
• Genetics

Background:

• Clinical and preclinical studies suggest reduced enkephalin tone is linked to depression.
• Enkephalin signaling enhancement is considered a potential therapeutic strategy for depression.

Purpose of the Study:

• To investigate the role of enkephalin in depression-related behaviors.
• To examine the impact of enkephalin deficiency on antidepressant efficacy.

Main Methods:

• Utilized knockout mice lacking the preproenkephalin gene (Penk1(-/-)).
• Assessed depression-related phenotypes using Porsolt forced swimming and tail suspension tests.
• Evaluated behavior in stress-induced hypoactivity and ultrasonic vocalization models.
• Tested the efficacy of various antidepressant drugs and a dual peptidase inhibitor (RB-101).

Main Results:

• Penk1(-/-) mice showed no depression-related phenotype in forced swimming or tail suspension tests.
• These mice exhibited reduced depression-related behavior in stress models, similar to antidepressant treatment.
• Antidepressant efficacy was generally similar between wild-type and Penk1(-/-) mice, with some compounds showing slightly enhanced effects in knockout animals.
• The dual peptidase inhibitor RB-101 was effective in Penk1(-/-) mice, despite expectations that its action relies on enkephalin.

Conclusions:

• Enkephalin deficiency does not necessarily lead to depression-related behaviors.
• The study challenges the established view of enkephalin's role in depression.
• Findings suggest alternative or complex mechanisms underlying antidepressant drug action and depression pathophysiology.